| Jun'18 | Jun'17 | ||||
|---|---|---|---|---|---|
Research and development expenses | |||||
0 | 0 | ||||
General and administrative expenses | |||||
0 | 0 | ||||
Total operating expense | |||||
0 | 0 | ||||
Other expenses | |||||
0 | 0 | ||||
Operating loss | |||||
0 | 0 | ||||
Finance income | |||||
0 | 0 | ||||
Finance expenses | |||||
0 | 0 | ||||
Loss | |||||
0 | 0 | ||||
Basic and diluted loss per share attributable to equity holders of the Company | |||||
0.01 | 0.03 | ||||
Basic and diluted loss per ADS attributable to equity holders of the Company | |||||
0.35 | 1.10 | ||||